Pfizer Limited (NSE:PFIZER)
4,650.00
-15.90 (-0.34%)
Sep 2, 2026, 3:29 PM IST
Pfizer Revenue
Pfizer had revenue of 6.53B INR in the quarter ending June 30, 2026, with 8.31% growth. This brings the company's revenue in the last twelve months to 25.70B, up 10.69% year-over-year. In the fiscal year ending March 31, 2026, Pfizer had annual revenue of 25.20B with 10.45% growth.
Revenue (ttm)
25.70B
Revenue Growth
+10.69%
P/S Ratio
8.24
Revenue / Employee
20.66M
Employees
1,244
Market Cap
211.70B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 25.20B | 2.38B | 10.45% |
| Mar 31, 2025 | 22.81B | 881.80M | 4.02% |
| Mar 31, 2024 | 21.93B | -2.32B | -9.55% |
| Mar 31, 2023 | 24.25B | -1.86B | -7.13% |
| Mar 31, 2022 | 26.11B | 3.71B | 16.54% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Zydus Lifesciences | 285.92B |
| Apollo Hospitals Enterprise | 264.30B |
| Divi's Laboratories | 112.30B |
| Alembic Pharmaceuticals | 77.84B |
| Sagility | 76.17B |
| Eris Lifesciences | 32.12B |
| Alivus Life Sciences | 25.90B |
Pfizer News
- 5 weeks ago - Pfizer Quarterly report: Q1 2027 - Filings
- 1 month ago - Pfizer announces Rs 75 per share final dividend with record date set for July 17, 2026 - Business Upturn
- 3 months ago - Pfizer Quarterly report: Q4 2026 - Filings
- 3 months ago - Pfizer Annual report: Q4 2026 - Filings
- 6 months ago - Pfizer Quarterly report: Q3 2026 - Filings
- 7 months ago - Pfizer appoints Nilesh Pendse as vaccines category lead; Manikantan Seshadrinathan exits senior management - Business Upturn
- 8 months ago - Pfizer signs exclusive 5-year supply and marketing pact with Cipla for four key brands - Business Upturn
- 9 months ago - Pfizer shares jump over 5% as Q2 profit rises 19% YoY on strong operational performance - Business Upturn